Literature DB >> 2174597

International bank for foot-and-mouth disease vaccine: stability studies with virus concentrates and vaccines prepared from them.

T R Doel1, L Pullen.   

Abstract

An international bank foot-and-mouth disease (FMD) vaccine has been established at the Pirbright Laboratory of the AFRC Institute for Animal Health. The bank is based on concentrated virus preparations stored in the gaseous phase of liquid nitrogen and is capable of producing up to 0.5 million cattle doses of each of five common strains of the virus (FMDV) for the member nations of the bank. This paper describes the initial and subsequent testing of the virus concentrates and vaccines prepared from them. There was no evidence of deterioration of the virus concentrates during liquid nitrogen storage. High levels of protection of cattle and guinea-pig were achieved when vaccines were used immediately following preparation from the recently thawed virus concentrates. In contrast, storage of vaccines at 4 degrees C for one or more months resulted in loss of potency in guinea-pigs and was attributed, in part to proteolytic enzymes in the virus concentrates.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2174597     DOI: 10.1016/0264-410x(90)90249-l

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

Review 1.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

2.  Immune responses of sheep to quadrivalent double emulsion foot-and-mouth disease vaccines: rate of development of immunity and variations among other ruminants.

Authors:  Prasanna K Patil; Jagadeesh Bayry; Chitimalla Ramakrishna; Basavesh Hugar; Laxmi D Misra; Krishnamsetty Prabhudas; C Natarajan
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

3.  An increase in acid resistance of foot-and-mouth disease virus capsid is mediated by a tyrosine replacement of the VP2 histidine previously associated with VP0 cleavage.

Authors:  Angela Vázquez-Calvo; Flavia Caridi; Francisco Sobrino; Miguel A Martín-Acebes
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

4.  Evaluation of the efficacy of a new oil-based adjuvant ISA 61 VG FMD vaccine as a potential vaccine for cattle.

Authors:  A Khorasani; O Madadgar; H Soleimanjahi; H Keyvanfar; H Mahravani
Journal:  Iran J Vet Res       Date:  2016       Impact factor: 1.376

5.  Characterization of epitope-tagged foot-and-mouth disease virus.

Authors:  Julian Seago; Terry Jackson; Claudia Doel; Elizabeth Fry; David Stuart; Michiel M Harmsen; Bryan Charleston; Nicholas Juleff
Journal:  J Gen Virol       Date:  2012-07-18       Impact factor: 3.891

6.  Quantitative Detection of the Foot-And-Mouth Disease Virus Serotype O 146S Antigen for Vaccine Production Using a Double-Antibody Sandwich ELISA and Nonlinear Standard Curves.

Authors:  Xia Feng; Jun-Wu Ma; Shi-Qi Sun; Hui-Chen Guo; Ya-Min Yang; Ye Jin; Guang-Qing Zhou; Ji-Jun He; Jian-Hong Guo; Shu-yun Qi; Mi Lin; Hu Cai; Xiang-Tao Liu
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.